Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 28.76% vs -11.83% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 121.40% vs -32.46% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 17.69% vs 97.09% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 146.45% vs -15.94% in Mar 2024
Compare Profit and Loss Results of Jagsonpal Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
268.00
32.00
236.00
737.50%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
268.00
32.00
236.00
737.50%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-3.00
1.00
33.33%
Raw Materials Consumed
98.00
11.00
87.00
790.91%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
70.00
6.00
64.00
1,066.67%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
0.00
24.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
217.00
19.00
198.00
1,042.11%
Operating Profit (PBDIT) excl Other Income
51.00
12.00
39.00
325.00%
Other Income
8.00
4.00
4.00
100.00%
Operating Profit (PBDIT)
59.00
16.00
43.00
268.75%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
58.00
16.00
42.00
262.50%
Depreciation
8.00
3.00
5.00
166.67%
Profit Before Taxation & Exceptional Items
50.00
13.00
37.00
284.62%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
69.00
13.00
56.00
430.77%
Provision for Tax
14.00
3.00
11.00
366.67%
Profit After Tax
55.00
9.00
46.00
511.11%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
104.00
37.00
67.00
181.08%
Profit Available for appropriations
159.00
47.00
112.00
238.30%
Appropriations
159.00
47.00
112.00
238.30%
Equity Dividend (%)
125%
1%
124.00
Earnings Per Share
8.26
0.22
8.04
3,654.55%
Profit And Loss - Net Sales
Net Sales 268.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.76% vs -11.83% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 121.40% vs -32.46% in Mar 2024
Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.69% vs 97.09% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 55.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 146.45% vs -15.94% in Mar 2024






